Department of Biosciences and Bioengineering at IIT Bombay.
Professor
Doctor in Immunology, researcher at and former director of the Autoimmunity-Transplantation-Inflammation research team at the INSERM-Univ Franche Comté-EFS Joint Research Unit 1098 RIGHT in Besançon (FR) for the last 10 years, Dr Perruche is now the founder and CEO of...
En savoir +After a master's degree in genetics and a Ph.D. on the role of Gas6 protein and precursor cells in steatohepatitis and hepatic fibrosis, Agnès advised companies in many sectors, particularly in industry, as a consultant in innovation financing. She was...
En savoir +PhD in molecular and cell therpay, research director at the INSERM-Univ Franche Comté-EFS Joint Research Unit 1098 RIGHT in Besançon (FR), Dr Christophe Ferrand is also the founder of advesya biotech company, a French clinical-stage biotech company founded in 2020....
En savoir +Celine ELIE-CAILLE obtained her Ph.D degree in enzymatic engineering from the University of Technology of Compiègne (UTC, France) in 2003. After a post-doctoral position at the BIOTEC Institute in Dresden (Germany) in 2004-2006 where she acquired skills in atomic force...
En savoir +Dr Olivier Humbey (PhD) is a Business Developer at IQVIA offering international Real World Data solutions to Biotechs at each stage of their product life cycle development (from early clinical to post-marketing). He works strategically with cross department services to...
En savoir +Laure obtained a PhD in Genetics at Imagine Institute of Necker hospital in Paris. During her PhD years, she was also implicated on the organization and communication of scientific events by being member of Young researchers of Imagine Institute association....
En savoir +After studying biology at the University of Sciences in Besançon, Sylvie defended her thesis based on cytogenetic and molecular prenatal diagnostic tools in Pr. Bresson's cytogenetics laboratories in Besançon. Then she went to Montreal, Quebec, as a laboratory coordinator at...
En savoir +Jessica Gobbo is an accomplished clinician-researcher with a profound specialization in oncology and translational medicine. She works as a researcher in the early-phase clinical trials unit at the Centre Georges-François Leclerc (CLCC) in Dijon and is a key member of...
En savoir +Jean-Luc Schlick holds a PhD in Biochemistry and Molecular Biology from Sciences University of Franche-Comté (Besancon, Fr). He is a co-founder of RD-BIOTECH SAS founded in 2002 with Philippe Dulieu and Jean-François Musard. In 2002, he was head of the...
En savoir +With 15 years' experience as a manager in the hotel and seminar industry, I joined the PMT events department in 2020. I was lucky enough to take part in the Innovative Therapies Days adventure from its very first edition in...
En savoir +John De Vos is Professor of Embryology, Histology and Regenerative Medicine at the Faculty of Medicine of Montpellier, and head of the Cellular and Tissue Engineering Department of the University Hospital Center (CHU) of Montpellier. His research, at the Research...
En savoir +European Regulation (EC) No 1394/2007 created a new class of drugs in 2007 called : “Advanced Therapy Medicinal Products”, resulting from cellular and tissue engineering, genetic manipulation, and possibly combined with medical devices. More than fifteen years after the implementation...
En savoir +From the beginning of my career in 2001 at the “Etablissement Français du Sang” (EFS, BFC, Besançon), I became interested in translational research and more particularly to modulate the T cells lymphocyte response, such as T cells involved in host-graft-tumor...
En savoir +